Can we predict cardiac rupture in patients with ST-segment elevation myocardial infarction?
- PMID: 35928604
- PMCID: PMC9344428
- DOI: 10.21037/jtd-22-655
Can we predict cardiac rupture in patients with ST-segment elevation myocardial infarction?
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-655/coif). ESB reports consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Elsevier, GE Healthcare, IMDS, InfraRedx, Medicure, Medtronic, Opsens, Siemens, and Teleflex; and research support from Boston Scientific, GE Healthcare; owner, Hippocrates LLC; shareholder: MHI Ventures, Cleerly Health, Stallion Medical. The other authors have no conflicts of interest to declare.
Comment on
-
Risk factors for cardiac rupture after acute ST-segment elevation myocardial infarction during the percutaneous coronary intervention era: a retrospective case-control study.J Thorac Dis. 2022 Apr;14(4):1256-1266. doi: 10.21037/jtd-22-394. J Thorac Dis. 2022. PMID: 35572908 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources